• Asplund CL, Todd JJ, Snyder AP, Marois R (2010). A central role for the lateral prefrontal cortex in goal-directed and stimulus-driven attention.Nat Neurosci13: 507–512.

  Article CAS  Google Scholar 

• Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué Set al (2013). Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.PLoS ONE8: e55821.

  Article CAS  Google Scholar 

• Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Prata Det al (2012a). Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function.Mol Psychiatry17: 1152–1155.

  Article CAS  Google Scholar 

• Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, McGuire PK (2012b). Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies.Curr Pharm Des18: 5045–5054.

  Article CAS  Google Scholar 

• Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli Pet al (2012c). Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.Arch Gen Psychiatry69: 27–36.

  Article CAS  Google Scholar 

• Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P (2009a). Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology.Curr Pharm Des15: 2603–2614.

  Article CAS  Google Scholar 

• Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O’Carroll Cet al (2009b). Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.Arch Gen Psychiatry66: 442–451.

  Article CAS  Google Scholar 

• Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown Tet al (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.Neuropsychopharmacology35: 764–774.

  Article CAS  Google Scholar 

• Bolton MM, Heaney CF, Sabbagh JJ, Murtishaw AS, Magcalas CM, Kinney JW (2012). Deficits in emotional learning and memory in an animal model of schizophrenia.Behav Brain Res233: 35–44.

  Article  Google Scholar 

• Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal MLet al (2008). Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.Biol Psychiatry64: 966–973.

  Article CAS  Google Scholar 

• Brammer MJ, Bullmore ET, Simmons A, Williams SC, Grasby PM, Howard RJet al (1997). Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach.Magn Reson Imaging15: 763–770.

  Article CAS  Google Scholar 

• Bullmore E, Long C, Suckling J, Fadili J, Calvert G, Zelaya Fet al (2001). Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains.Hum Brain Mapp12: 61–78.

  Article CAS  Google Scholar 

• Burianova H, McIntosh AR, Grady CL (2010). A common functional brain network for autobiographical, episodic, and semantic memory retrieval.Neuroimage49: 865–874.

  Article  Google Scholar 

• Corlett PR, Honey GD, Aitken MRF, Dickinson A, Shanks DR, Absalom ARet al (2006). Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.Arch Gen Psychiatry63: 611–621.

  Article  Google Scholar 

• Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire Pet al (2009). Cannabis and anxiety: a critical review of the evidence.Hum Psychopharmacol24: 515–523.

  Article CAS  Google Scholar 

• D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu Y-Tet al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.Neuropsychopharmacology29: 1558–1572.

  Article  Google Scholar 

• D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley Get al (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.Biol Psychiatry57: 594–608.

  Article  Google Scholar 

• Diaconescu AO, Menon M, Jensen J, Kapur S, McIntosh AR (2010). Dopamine-induced changes in neural network patterns supporting aversive conditioning.Brain Res1313: 143–161.

  Article CAS  Google Scholar 

• Esposito R, Cilli F, Pieramico V, Ferretti A, Macchia A, Tommasi Met al (2013). Acute effects of modafinil on brain resting state networks in young healthy subjects.PLoS ONE8: e69224.

  Article CAS  Google Scholar 

• Filbey F, Yezhuvath U (2013). Functional connectivity in inhibitory control networks and severity of cannabis use disorder.Am J Drug Alcohol Abuse39: 382–391.

  Article  Google Scholar 

• Floresco SB, West AR, Ash B, Moore H, Grace AA (2003). Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission.Nat Neurosci6: 968–973.

  Article CAS  Google Scholar 

• Friston KJ (2011). Functional and effective connectivity: a review.Brain Connect1: 13–36.

  Article  Google Scholar 

• Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt Set al (2010). Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.Int J Neuropsychopharmacol13: 421–432.

  Article CAS  Google Scholar 

• Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos Ret al (2009). Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.Arch Gen Psychiatry66: 95–105.

  Article CAS  Google Scholar 

• Gollub RL, Breiter HC, Kantor H, Kennedy D, Gastfriend D, Mathew RTet al (1998). Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects.J Cereb Blood Flow Metab18: 724–734.

  Article CAS  Google Scholar 

• Guillin O, Abi-Dargham A, Laruelle M (2007). Neurobiology of dopamine in schizophrenia.Int Rev Neurobiol78: 1–39.

  Article CAS  Google Scholar 

• Jensen J, Kapur S (2009). Salience and psychosis: moving from theory to practise.Psychol Med39: 197–198.

  Article CAS  Google Scholar 

• Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophr Bull13: 261.

  Article CAS  Google Scholar 

• Kuepper R, Morrison PD, van Os J, Murray RM, Kenis G, Henquet C (2010). Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.Schizophr Res121: 107–117.

  Article  Google Scholar 

• Kuepper R, van Os J, Lieb R, Wittchen H-U, Höfler M, Henquet C (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.BMJ342: d738.

  Article  Google Scholar 

• Kumaran D, Maguire EA (2006). An unexpected sequence of events: mismatch detection in the human hippocampus.PLoS Biol4: e424.

  Article  Google Scholar 

• Laviolette SR, Grace AA (2006). Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs.J Neurosci26: 6458–6468.

  Article CAS  Google Scholar 

• Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer Cet al (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.Transl Psychiatry2: e94.

  Article CAS  Google Scholar 

• Luo F, Wu G, Li Z, Li S-J (2003). Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain.Magn Reson Med49: 264–270.

  Article  Google Scholar 

• Meyer-Lindenberg A (2010). From maps to mechanisms through neuroimaging of schizophrenia.Nature468: 194–202.

  Article CAS  Google Scholar 

• Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke Met al (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.Lancet370: 319–328.

  Article  Google Scholar 

• Morgan CJA, Curran HV (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.Br J Psychiatry192: 306–307.

  Article  Google Scholar 

• Morgan CJA, Freeman TP, Schafer GL, Curran HV (2010a). Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.Neuropsychopharmacology35: 1879–1885.

  Article CAS  Google Scholar 

• Morgan CJA, Schafer G, Freeman TP, Curran HV (2010b). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].Br J Psychiatry197: 285–290.

  Article  Google Scholar 

• Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen Ret al (2011). Disruption of frontal theta coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms.Neuropsychopharmacology36: 827–836.

  Article CAS  Google Scholar 

• Murphy K, Dixon V, LaGrave K, Kaufman J, Risinger R, Bloom Aet al (2006). A validation of event-related fMRI comparisons between users of cocaine, nicotine, or cannabis and control subjects.Am J Psychiatry163: 1245–1251.

  Article  Google Scholar 

• Palaniyappan L, Liddle PF (2012). Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction.J Psychiatry Neurosci37: 17–27.

  Article  Google Scholar 

• Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.Br J Pharmacol153: 199–215.

  Article CAS  Google Scholar 

• Pettersson-Yeo W, Allen P, Benetti S, McGuire P, Mechelli A (2011). Dysconnectivity in schizophrenia: where are we now?Neurosci Biobehav Rev35: 1110–1124.

  Article  Google Scholar 

• Pujol J, Blanco-Hinojo L, Batalla A, López-Solà M, Harrison BJ, Soriano-Mas Cet al (2013). Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users.J Psychiatr Res51: 68–78.

  Article  Google Scholar 

• Rubia K, Smith AB, Brammer MJ, Taylor E (2007). Temporal lobe dysfunction in medication-naïve boys with attention-deficit/hyperactivity disorder during attention allocation and its relation to response variability.Biol Psychiatry62: 999–1006.

  Article  Google Scholar 

• Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver Fet al (2010). Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.Neuropsychopharmacology35: 1415–1422.

  Article CAS  Google Scholar 

• Selemon LD, Goldman-Rakic PS (1985). Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey.J Neurosci5: 776–794.

  Article CAS  Google Scholar 

• Stone JM, Morrison PD, Brugger S, Nottage J, Bhattacharyya S, Sumich Aet al (2012). Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence.Mol Psychiatry17: 568–569.

  Article CAS  Google Scholar 

• Strange BA, Dolan RJ (2001). Adaptive anterior hippocampal responses to oddball stimuli.Hippocampus11: 690–698.

  Article CAS  Google Scholar 

• Talairach J, Tournoux P (1988)Co-planar Stereotaxic Atlas of the Human Brain. Thieme Medical: New York.

  Google Scholar 

• Vita A, De Peri L, Silenzi C, Dieci M (2006). Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies.Schizophr Res82: 75–88.

  Article CAS  Google Scholar 

• Zink CF, Pagnoni G, Chappelow J, Martin-Skurski M, Berns GS (2006). Human striatal activation reflects degree of stimulus saliency.Neuroimage29: 977–983.

  Article  Google Scholar 

• Zuardi AW, Crippa JAS, Hallak JEC, Bhattacharyya S, Atakan Z, Martín-Santos Ret al (2012). A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation.Curr Pharm Des13: 5131–5140.

  Article  Google Scholar 

• Zuardi AW, Crippa JAS, Hallak JEC, Pinto JP, Chagas MHN, Rodrigues GGRet al (2009). Cannabidiol for the treatment of psychosis in Parkinson’s disease.J Psychopharmacol (Oxford)23: 979–983.

  Article CAS  Google Scholar 

Download references